Cancer biotech Inhibrx files for USD 75 M IPO Celgene-partnered biotech Inhibrx aftersecuring USD 40 Million from Viking Global Investors, has filed for USD 75 million…
Cancer biotech Inhibrx files for USD 75 M IPO Celgene-partnered biotech Inhibrx aftersecuring USD 40 Million from Viking Global Investors, has filed for USD 75 million…
Phone
India: +91-11-45689769, +91-9650213330Address
New Delhi-110075, IndiaAddress
304 S. Jones Blvd #2432, Las Vegas NV 89107Phone
Outside India: +1(919)321-6187
